IFNG and neoplasm: A pilot study explored the efficacy of the personalized peptide-loaded dendritic cell vaccine, Neo-DCVac, in patients with advanced lung cancer.283 The T-cell response assay verified a strong increase in IFNγ secretion and cytotoxicity, thereby strengthening the efficiency of tumor therapy.